Normalair-Garrettfibreglass, air-portable chamber ated healing were obtained in pyogenic infections, and in gas gangrene there was dramatic recovery from toxemia, preservation of tissue and often of life. Shock, burns, vascular injury, fractures and soft tissue himatomas complicate war wounds and, while HBO is no substitute for adequate fluid replacement, the correction of acid-base imbalance and skilled surgery, it may nevertheless be the factor in the post-operative course which conserves tissue and reduces morbidity.
With regard to the adverse effects of oxygen under pressure, 36 patients remained entirely unaffected by therapy throughout treatment, 3 convulsed, 3 vomited and 1 developed bilateral htmotympanum. Three experienced claustrophobia and the remaining 11 suffered temporary minor discomfort. The only serious complication therefore was oxygen convulsions, which had an incidence of just over 5 % and appeared directly related to the length of treatment (over 6 days) or to a pre-exisiting chronic hypoxia: J L Patterson, J P Baker, M A Tattersall and L Stringer (unpublished; quoted New Engl. J. Med 1966) have drawn attention to the importance of this latter condition.
Since gas gangrene is a serious and often fatal disease and the serviceman may frequently be at risk, there seems a good case for providing an airportable one-man chamber in theatres of war. The heavy metal naval one-man compression chamber first used weighs 580 lb (263 kg). It is hot in the tropics and provides inadequate patient observation. The Vickers chamber, which has been found excellent for routine hospital treatment, is a sophisticated piece of equipment with electronic monitoring of closed-circuit oxygen recirculation and humidity systems. It requires expert maintenance. We therefore considered the Normalair lightweight fibreglass chamber, developed initially by Smith et al. (1966) , and we have modified the prototype to produce a versatile, lightweight chamber weighing only 200 lb (91 kg) mounted on skids for air transportation and capable of being fitted to a trolley for hospital or sick quarters use. Since there is no electrical circuitry, it is both safe and robust and can be compressed with either air or oxygen (Fig 4) . The prototype had a protective guard over the Perspex dome which is now double skinned and this has been omitted by the manufacturers in the final version. We have therefore recommended that it be replaced. When this has been done, the chamber should provide a reasonably foolproof and safe method of making HBO available to the serviceman wounded on contaminated soil anywhere in the world.
Group Captain J N C Cooke (Royal Air Force Hospital, Wegberg, BFPO 40) Hyperbaric Oxygen Treatment in the Royal Air Force Regular treatment of patients with hyperbaric oxygen therapy (HBO) began at Princess Alexandra's Royal Air Force Hospital, Wroughton, in 1965. The original equipment consisted of a Royal Navy recompression chamber modified for mask breathing of oxygen which was later supplemented by a Vickers single patient chamber. Between 1965 and the end of 1969 a total of 65 patients were treated. In the first 2 years the majority consisted of traumatic service casualties but later on the facilities of the unit were made available for National Health Service patients from the local region. The variety of diagnoses is shown in Table 1 . A number of the traumatic cases were readmitted for further stages of treatment. These orthopxedic cases were mainly problems of chroinic wound infection, osteomyelitis and nonunion. The varicose ulcers were severe cases of long standing, where ordinary methods had failed. The air embolism cases occurred in a SCUBA diver and in a patient undergoing cardiac catheterization.
Results
It is obviously not possible to draw definite conclusions from a limited experience but we were able to compare our impression with other published series. First, HBO therapy is clearly indicated in the treatment of air embolism and gas gangrene. We had little experience of gas gangrene which is rare in our region.
The Clostridium welchii cases did well but one case with infection due to a gas-forming E. coli organism received no benefit. Slack (1968, personal communication) has noted similar disappointments. The air embolism cases were both treated very late after onset. The SCUBA diver was admitted in an unconscious and moribund state six hours after embolism but recovered after recompression to have no more than residual monoparesis of one arm. The other case of air embolism recovered completely although there was a similar delay before treatment. We concluded that it is never too late to try compression therapy in these cases while the patient still lives.
Our experience with leg ulceration confirmed the reports of Bass (1970) and Fischer (1969) . Varicose ulceration healed rapidly and some extremely severe cases with histories of repeated breakdown after standard methods of treatment have continued without further trouble for over two years after HBO therapy. However, ulceration associated with ischmmia due to arterial disease seemed to show only transient improvement with HBO. In general the same observation applied to all the cases of peripheral vascular disease of the chronic type.
Many of our patients were suffering from traumatic and orthopedic lesions complicated by chronic infection. Dramatic improvement would not be expected with any therapy and a controlled matched trial was clearly impractical. However, our surgeons were impressed that HBO offered an ancillary treatment which, when integrated with standard procedures, appeared to accelerate the elimination of infection by antibiotics and also the successful closure of wounds with or without grafting. Where there was associated serious vascular damage HBO seemed to allow of delay in operative decisions without serious danger and may in some cases have allowed conservation of tissue originally doubted to be viable. Some of these cases had repeated courses of H11O at various stages of their treatment. With more acute vascular disorders such as frostbite it seemed to be worthwhile to use HBO, particularly to secure good results from grafting.
Side-effects of HBO therapy were few. There were occasional instances of otitic barotrauma and a few patients complained of claustrophobia and anxiety. Symptoms ofoxygen toxicity were not seen with the standard pressures and exposures used.
Our tentative conclusions are that, despite the cost in equipment and man hours, HBO therapy centres on a regional basis are clearly required for the treatment of a few conditions while providing useful ancillary treatment in a large number of conditions arising in service medicine. The availability of these centres for civilian patients will improve liaison and the experience of the operators. HBO treatment is finding its true place in the therapeutic armoury and the Services should be involved in its future developments.
